Skip to content
Group parent company V-Bio Fund 20759.685.291

V-Bio Fund 2

ActiveGent, parent founded in 2020JAY THERAPEUTICS
2
companies
in 1 country
In Belgium 2 companies
Parent's equity€51.8mown accounts 2025
Follow this groupParent's dossier
V-Bio Fund 2
Financial year 2025
Follow this groupParent's dossier

Insights on V-Bio Fund 2

In 2023 the parent booked a loss of €3.9m and its equity fell from €13.1m to €19.2m.

Sources: the lists of holdings in the annual accounts of the group's companies (1 in 2025), their own annual accounts, the establishment units in the KBO and the ECB rates.
Equity
FTE
Standalone accounts

Events in the group

These are the publications about all Belgian group companies, such as bankruptcies, director changes and capital changes. Deeds are listed since January 2026, judgments from earlier years too.

3
  1. Dissolution with immediate closure of the liquidation
    DissolutionJAY THERAPEUTICSDissolved and wound up in a single deed on 17-07-2026 · No liquidator appointed · Books and records kept in Ghent
  2. 2 directors resigning
    Director changeJAY THERAPEUTICSResigned: ROSENKRANZ Katja and VANPOUCKE Griet · Dissolved and wound up in a single deed on 17-07-2026
  3. Capital increase of €22,000,000 to €88,100,000
    Capital changeV-Bio Fund 2Capital from €66,100,000 to €88,100,000, 22,000,000 new shares · Amendment of the articles

Peppol

Peppol Directory
1 of 2
Belgian companies listed

Source: Peppol Directory.

Your exposure to this group

We would like to set cookies. That happens only with your consent. What we measure